<code id='B61B9B6C63'></code><style id='B61B9B6C63'></style>
    • <acronym id='B61B9B6C63'></acronym>
      <center id='B61B9B6C63'><center id='B61B9B6C63'><tfoot id='B61B9B6C63'></tfoot></center><abbr id='B61B9B6C63'><dir id='B61B9B6C63'><tfoot id='B61B9B6C63'></tfoot><noframes id='B61B9B6C63'>

    • <optgroup id='B61B9B6C63'><strike id='B61B9B6C63'><sup id='B61B9B6C63'></sup></strike><code id='B61B9B6C63'></code></optgroup>
        1. <b id='B61B9B6C63'><label id='B61B9B6C63'><select id='B61B9B6C63'><dt id='B61B9B6C63'><span id='B61B9B6C63'></span></dt></select></label></b><u id='B61B9B6C63'></u>
          <i id='B61B9B6C63'><strike id='B61B9B6C63'><tt id='B61B9B6C63'><pre id='B61B9B6C63'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:46
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Why the world’s most expensive drug might be worth the price
          Why the world’s most expensive drug might be worth the price

          AdobeThestaffoftheInstituteforClinicalandEconomicReview,orICER,areknownasthenerdsofthedrugindustry:b

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Covid vaccine financial winners and losers, from Pfizer to Novavax

          Illustration:ChristineKao/STAT;Photos:GettyIt’sbeenfouryearssinceCovid-19emerged,ignitingapandemicth